<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39346932</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2514-6645</ISSN><JournalIssue CitedMedium="Print"><Volume>11</Volume><Issue>4</Issue><PubDate><Year>2024</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Future healthcare journal</Title><ISOAbbreviation>Future Healthc J</ISOAbbreviation></Journal><ArticleTitle>Implementation of facemask sampling for the detection of infectious individuals with SARS-CoV-2 in high stakes clinical examinations - a feasibility study.</ArticleTitle><Pagination><StartPage>100175</StartPage><MedlinePgn>100175</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100175</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.fhj.2024.100175</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">SARS-CoV-2 may transmit across vaccinated cohorts during practical clinical examinations. We sought to assess the feasibility of facemask sampling (FMS) to identify individuals emitting SARS-CoV-2 during a mock PACES exam.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In May 2022 we recruited participants from a mock PACES examination in Leicester, UK. Following a negative lateral flow test assay, all participants wore modified facemasks able to capture exhaled virus during the assessment (FMS). A concomitant upper respiratory tract sample (URTS) was provided prior to FMS. Exposed facemasks were processed by removal and dissolution of sampling matrices fixed within the mask and cycle thresholds values quantified by RT-qPCR. Participants were asked to grade statements regarding the comfort, effort, ethics and communication when providing FMS; laboratory technicians were asked to grade key statements surrounding suitability of samples for processing.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">34 participants provided concomitant URTS and FMS during the examination. One participant was positive for SARS-CoV-2, with a cycle threshold value of 22.5 on URTS, but negative (no viral RNA detected) on FMS; no transmission to others was identified from this individual. Participants responded positively to statements regarding FMS describing all four domains; however, 69% of participants felt that a positive result from FMS alone was insufficient for diagnosis and that further tests were required. All but one FMS sample was suitable for processing.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">FMS during PACES exams are acceptable among participants and samples provided are suitable for processing. Our results demonstrate feasibility of FMS within practical examination settings and support the further assessment of FMS as a scalable tool that can be compared with URTS to identify those who are infectious.</AbstractText><CopyrightInformation>© 2024 The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Pan</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Development Centre for Population Health, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Li Ka Shing Centre for Health Information and Discovery, University of Oxford, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>WHO Collaborating Centre for Infectious Disease Epidemiology and Control, School of Public Health, Li Ka Sing Faculty of Medicine, University of Hong Kong, Hong Kong, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Williams</LastName><ForeName>Caroline</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Decker</LastName><ForeName>Jonathan</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fletcher</LastName><ForeName>Eve</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grolmusova</LastName><ForeName>Natalia</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bird</LastName><ForeName>Paul W</ForeName><Initials>PW</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Christopher A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Development Centre for Population Health, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazareth</LastName><ForeName>Joshua</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Development Centre for Population Health, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rahman</LastName><ForeName>Latif</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Acute Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Kelly</LastName><ForeName>Kate</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Panchal</LastName><ForeName>Rakesh</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Respiratory Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Musa</LastName><ForeName>Irfana</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Geriatric Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dhutia</LastName><ForeName>Harshil</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sze</LastName><ForeName>Shirley</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Cardiology, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiovascular Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pareek</LastName><ForeName>Manish</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Development Centre for Population Health, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Infectious Diseases and HIV Medicine, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Leicester Biomedical Research Centre, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barer</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Department of Respiratory Sciences, University of Leicester, UK.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Microbiology, University Hospitals of Leicester NHS Trust, UK.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Future Healthc J</MedlineTA><NlmUniqueID>101711246</NlmUniqueID><ISSNLinking>2514-6645</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Acceptability</Keyword><Keyword MajorTopicYN="N">Examination</Keyword><Keyword MajorTopicYN="N">PACES</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">Transmission</Keyword></KeywordList><CoiStatement>The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Daniel Pan is funded by a National Institute for Health and Care Research Doctoral Research Fellowship (NIHR award number: NIHR302338). The other authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>16</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>30</Day><Hour>9</Hour><Minute>58</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>5</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39346932</ArticleId><ArticleId IdType="pmc">PMC11437942</ArticleId><ArticleId IdType="doi">10.1016/j.fhj.2024.100175</ArticleId><ArticleId IdType="pii">S2514-6645(24)01565-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Royal College of Physicians. PACES. 2022. Available from: https://www.mrcpuk.org/mrcpuk-examinations/paces.</Citation></Reference><Reference><Citation>Antonelli M, Penfold RS, Merino J, et al. Risk factors and disease profile of post-vaccination SARS-CoV-2 infection in UK users of the COVID Symptom Study app: a prospective, community-based, nested, case-control study. Lancet Infect Dis. 2022;22(1):43–55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8409907</ArticleId><ArticleId IdType="pubmed">34480857</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians. PACES and the removal of social distancing in England. 2021. Available from: https://www.mrcpuk.org/news/paces-and-removal-social-distancing-england.</Citation></Reference><Reference><Citation>Deeks JJ, Singanayagam A, Houston H, et al. SARS-CoV-2 antigen lateral flow tests for detecting infectious people: linked data analysis. BMJ. 2022;376</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8864475</ArticleId><ArticleId IdType="pubmed">35197270</ArticleId></ArticleIdList></Reference><Reference><Citation>Kliegr T, Jarkovský J, Jiřincová H, Kuchař J, Karel T, Tachezy R. Role of population and test characteristics in antigen-based SARS-CoV-2 diagnosis, Czechia, August to November 2021. Eurosurveillance. 2022;27(33):1–15. doi: 10.2807/1560-7917.ES.2022.27.33.2200070. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2022.27.33.2200070</ArticleId><ArticleId IdType="pmc">PMC9389858</ArticleId><ArticleId IdType="pubmed">35983773</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakki S, Zhou J, Jonnerby J, et al. Onset and window of SARS-CoV-2 infectiousness and temporal correlation with symptom onset: a prospective, longitudinal, community cohort study. Lancet Respir Med. 2022:1061–1073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9388060</ArticleId><ArticleId IdType="pubmed">35988572</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan D, Williams CM, Decker J, et al. Exhaled SARS-CoV-2 RNA viral load kinetics measured by facemask sampling associates with household transmission. Clin Microbiol Infect. 2022 doi: 10.1016/j.cmi.2022.07.005. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2022.07.005</ArticleId><ArticleId IdType="pmc">PMC9281452</ArticleId><ArticleId IdType="pubmed">35843566</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams CM, Pan D, Decker J, et al. Exhaled SARS-CoV-2 quantified by face-mask sampling in hospitalised patients with COVID-19. J Infect. 2021;82(6):253–259. doi: 10.1016/j.jinf.2021.03.018. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.03.018</ArticleId><ArticleId IdType="pmc">PMC7989096</ArticleId><ArticleId IdType="pubmed">33774019</ArticleId></ArticleIdList></Reference><Reference><Citation>Royal College of Physicians. PACES examination format. 2022. Available from: https://www.mrcpuk.org/mrcpuk-examinations/paces/paces-examination-format.</Citation></Reference><Reference><Citation>Singanayagam A, Hakki S, Dunning J, et al. Community transmission and viral load kinetics of the SARS-CoV-2 delta (B.1.617.2) variant in vaccinated and unvaccinated individuals in the UK: a prospective, longitudinal, cohort study. Lancet Infect Dis. 2021;3099(21)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8554486</ArticleId><ArticleId IdType="pubmed">34756186</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung NHL. Transmissibility and transmission of respiratory viruses. Nat Rev Microbiol. 2021 doi: 10.1038/s41579-021-00535-6. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41579-021-00535-6</ArticleId><ArticleId IdType="pmc">PMC7982882</ArticleId><ArticleId IdType="pubmed">33753932</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung NHL, Chu DKW, Shiu EYC, et al. Respiratory virus shedding in exhaled breath and efficacy of face masks. Nat Med. 2020;26(5):676–680. doi: 10.1038/s41591-020-0843-2. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0843-2</ArticleId><ArticleId IdType="pmc">PMC8238571</ArticleId><ArticleId IdType="pubmed">32371934</ArticleId></ArticleIdList></Reference><Reference><Citation>Adenaiye OO, Lai J, Bueno de Mesquita PJ, et al. Infectious Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in exhaled aerosols and efficacy of masks during early mild infection. Clin Infect Dis. 2022;75(1):e241–e248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8522431</ArticleId><ArticleId IdType="pubmed">34519774</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng Y, Ma N, Witt C, et al. Face masks effectively limit the probability of SARS-CoV-2 transmission. Science (80-) 2021;372(6549):1339–1343.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8168616</ArticleId><ArticleId IdType="pubmed">34016743</ArticleId></ArticleIdList></Reference><Reference><Citation>Butt AA, Yan P, Shaikh OS, Mayr FB, Omer SB. Rate and risk factors for severe/critical disease among fully vaccinated persons with breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection in a high-risk national population. Clin Infect Dis. 2022;75(1):e849–e856.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8689859</ArticleId><ArticleId IdType="pubmed">34893812</ArticleId></ArticleIdList></Reference><Reference><Citation>Boekel L, Stalman EW, Wieske L, et al. Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. Lancet Rheumatol. 2022;4(6):e417–e429.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9054068</ArticleId><ArticleId IdType="pubmed">35527808</ArticleId></ArticleIdList></Reference><Reference><Citation>Esposito AJ, Menon AA, Ghosh AJ, et al. Increased odds of death for patients with interstitial lung disease and COVID-19: a case–control study. Am J Respir Crit Care Med. 2020;202(12):1710–1713.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7737588</ArticleId><ArticleId IdType="pubmed">32897754</ArticleId></ArticleIdList></Reference><Reference><Citation>Estabragh ZR-, Cooper J, Salih A, et al. Cardiovascular disease and mortality sequelae of 19 in the UK Biobank. 2022;(Cvd):1–8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9811071</ArticleId><ArticleId IdType="pubmed">36280346</ArticleId></ArticleIdList></Reference><Reference><Citation>Sulzer D, Antonini A, Leta V, et al. COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside. npj Park Dis. 2020;6(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7441399</ArticleId><ArticleId IdType="pubmed">32885037</ArticleId></ArticleIdList></Reference><Reference><Citation>Demir E, Ucar ZA, Dheir H, et al. COVID-19 in kidney transplant recipients: a multicenter experience from the first two waves of pandemic. BMC Nephrol. 2022;23(1):1–13. doi: 10.1186/s12882-022-02784-w. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12882-022-02784-w</ArticleId><ArticleId IdType="pmc">PMC9097147</ArticleId><ArticleId IdType="pubmed">35550025</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips G, Jones M, Dagg K. Restarting training and examinations in the era of covid-19: a perspective from the federation of royal colleges of physicians UK. Clin Med J R Coll Phys Lond. 2020;20(6):1–5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7687339</ArticleId><ArticleId IdType="pubmed">32912965</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou J, Singanayagam A, Goonawardane N, et al. Viral emissions into the air and environment after SARS-CoV-2 human challenge: a phase 1, open label, first-in-human study. Lancet Microbe. 2023;4(8):e579–e590. doi: 10.1016/S2666-5247(23)00101-5. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2666-5247(23)00101-5</ArticleId><ArticleId IdType="pmc">PMC10256269</ArticleId><ArticleId IdType="pubmed">37307844</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim HS, Lee H, Park J, et al. Collection and detection of SARS-CoV-2 in exhaled breath using face mask. PLoS One. 2022;17:1–12. 8 August.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9387863</ArticleId><ArticleId IdType="pubmed">35980889</ArticleId></ArticleIdList></Reference><Reference><Citation>Sriraman K, Shaikh A, Parikh S, et al. Non-invasive adapted N-95 mask sampling captures variation in viral particles expelled by COVID-19 patients: implications in understanding SARS-CoV2 transmission. PLoS One. 2021;16:1–11. 4 April.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8041197</ArticleId><ArticleId IdType="pubmed">33844696</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallichotte EN, Windsor W, Watts S, et al. Detection of SARS-CoV-2 in exhaled air using non-invasive embedded strips in masks. Am J Infect Control. 2022;50(8):890–897. doi: 10.1016/j.ajic.2022.01.010. Available from.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajic.2022.01.010</ArticleId><ArticleId IdType="pmc">PMC9329094</ArticleId><ArticleId IdType="pubmed">35908828</ArticleId></ArticleIdList></Reference><Reference><Citation>Ng DHL, Sim MY, Huang HH, Sim JXY, Low JGH, Lim JKS. Feasibility and utility of facemask sampling in the detection of SARS-CoV-2 during an ongoing pandemic. Eur J Clin Microbiol Infect Dis. 2021;40(12):2489–2496.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256409</ArticleId><ArticleId IdType="pubmed">34224033</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>